Literature DB >> 15864893

Evaluation of chronic dyspnea.

Neel G Karnani1, Gary M Reisfield, George R Wilson.   

Abstract

Chronic dyspnea is defined as dyspnea lasting more than one month. In approximately two thirds of patients presenting with dyspnea, the underlying cause is cardiopulmonary disease. Establishing an accurate diagnosis is essential because treatment differs depending on the underlying condition. Asthma, congestive heart failure, chronic obstructive pulmonary disease, pneumonia, cardiac ischemia, interstitial lung disease, and psychogenic causes account for 85 percent of patients with this principal symptom. The history and physical examination should guide selection of initial diagnostic tests such as electrocardiogram, chest radiograph, pulse oximetry, spirometry, complete blood count, and metabolic panel. If these are inconclusive, additional testing is indicated. Formal pulmonary function testing may be needed to establish a diagnosis of asthma, chronic obstructive pulmonary disease, or interstitial lung disease. High-resolution computed tomography is particularly useful for diagnosing interstitial lung disease, idiopathic pulmonary fibrosis, bronchiectasis, or pulmonary embolism. Echocardiography and brain natriuretic peptide levels help establish a diagnosis of congestive heart failure. If the diagnosis remains unclear, additional tests may be required. These include ventilation perfusion scans, Holter monitoring, cardiac catheterization, esophageal pH monitoring, lung biopsy, and cardiopulmonary exercise testing.

Entities:  

Mesh:

Year:  2005        PMID: 15864893

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  15 in total

1.  Evaluation of stat orders in a teaching hospital: a chart review.

Authors:  Fanak Fahimi; Zahra Sahraee; Shahideh Amini
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  The patient with dyspnea. Rational diagnostic evaluation.

Authors:  S Brenner; G Güder
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

3.  Dyspnea Management in Early Stage Lung Cancer: A Palliative Perspective.

Authors:  Anna Cathy Williams; Marcia Grant; Brian Tiep; Jae Y Kim; Jennifer Hayter
Journal:  J Hosp Palliat Nurs       Date:  2012-07       Impact factor: 1.918

4.  Arsenic exposure from drinking water and dyspnoea risk in Araihazar, Bangladesh: a population-based study.

Authors:  Gene R Pesola; Faruque Parvez; Yu Chen; Alauddin Ahmed; Rabiul Hasan; Habibul Ahsan
Journal:  Eur Respir J       Date:  2011-11-16       Impact factor: 16.671

Review 5.  Diagnostic approach to chronic dyspnoea in adults.

Authors:  Olivia R Ferry; Yao C Huang; Philip J Masel; Michael Hamilton; Kwun M Fong; Rayleen V Bowman; Scott C McKenzie; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

6.  Molecular characterization of Arabidopsis PHO80-like proteins, a novel class of CDKA;1-interacting cyclins.

Authors:  J A Torres Acosta; J de Almeida Engler; J Raes; Z Magyar; R De Groodt; D Inzé; L De Veylder
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

Review 7.  Dyspnea as an independent predictor of mortality.

Authors:  Gene R Pesola; Habibul Ahsan
Journal:  Clin Respir J       Date:  2014-08-20       Impact factor: 2.570

8.  Diagnosis of the cause of chronic dyspnoea in primary and tertiary care: characterizing diagnostic confidence.

Authors:  Yao C Huang; Olivia R Ferry; Scott C McKenzie; Rayleen V Bowman; Michael Hamilton; Philip J Masel; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

9.  Chronic dyspnoea: finding the cause to reduce mortality.

Authors:  Gene R Pesola; Vikhyath Terla; Nasir Malik; Habibul Ahsan
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

10.  Objective Scoring of Physiologically Induced Dyspnea by Non-Invasive RF Sensors.

Authors:  Zijing Zhang; Pragya Sharma; Thomas Conroy; Veerawat Phongtankuel; Edwin Chihchuan Kan
Journal:  IEEE Trans Biomed Eng       Date:  2021-12-23       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.